Crofed

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Crofed

Property Description
Active Ingredients Pseudoephedrine, Triprolidine
Form Oral Tablet, Oral Liquid (Syrup)
Pharmacological Class Antihistamine/Decongestant Combination
Origin Synthetic

Defining Crofed: A Fixed Combination Drug

Crofed is a medicinal entity classified as an Upper Respiratory Combination agent, specifically formulated to integrate the distinct active components Pseudoephedrine and Triprolidine into a single dosage form. This formulation is a synthetic product, designed to address multiple, often co-occurring, symptoms of respiratory discomfort. Its identity as a combination product is crucial, differentiating it from single-agent medications, which contain only one active ingredient. This dual approach is clinically recognized for its efficacy in providing comprehensive symptomatic relief in a unified delivery method.

Active Components and Therapeutic Function

This product's composition relies on the two key active ingredients: Pseudoephedrine and Triprolidine. Pseudoephedrine is categorized pharmacologically as a Sympathomimetic Agent, working primarily as a nasal decongestant. Triprolidine is classified as a First-generation H1-Antagonist, providing the antiallergic effects. The oral route of administration is typical, with the medicine available as an Oral Tablet and an Oral Liquid (Syrup).

The primary function of this combination is to offer coordinated symptomatic relief. Pseudoephedrine achieves its effect through vasoconstriction—the narrowing of blood vessels in the nasal passages—which directly reduces tissue swelling and clears congestion. Triprolidine, in parallel, works by competitively blocking the action of histamine at the H1-receptor sites, mitigating the allergic response and reducing excessive secretions. This integrated approach ensures the product provides both congestion relief and a reduction in histamine-driven discomfort, making it suitable for periods of seasonal allergies.

Regulatory References

  1. pseudoephedrine, triprolidine drug combination MeSH Subject Heading
  2. Label: APRODINE - Pseudoephedrine HCl and Tripolidine HCl Tablet, DailyMed

What side effects are possible with Crofed?

Possible side effects and safety information

The safety profile for Crofed (Pseudoephedrine/Triprolidine) is officially documented by government regulatory agencies, outlining adverse reactions grouped by frequency and the body system affected.


Adverse Reactions: Frequency and System

Adverse reactions are classified into standardized frequency categories, with the most commonly documented effects relating to the Central Nervous System (CNS) and the Anticholinergic effects of the first-generation antihistamine component.

Classification Examples of Officially Documented Effects
Common Drowsiness, dry mouth, headache, nausea, nervousness, sleep disturbance.
Uncommon/Rare Hypertension, palpitations, tachycardia, confusion, hallucinations, severe hypersensitivity reactions, urinary retention.

Major System-Organ Classes involved include Nervous System Disorders, Gastrointestinal Disorders (e.g., dry mouth, constipation), Cardiac Disorders, and Vascular Disorders.


Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight the risk of rare but serious adverse reactions, which include psychotic reactions and hallucinations (particularly noted in children), severe hypertensive events, and very rare cases of Ischaemic Colitis.

Use is subject to specific regulatory restrictions and limitations. The medicine is contraindicated in individuals with severe hypertension or severe coronary artery disease. It must not be used concurrently with or within 14 days of taking Monoamine Oxidase Inhibitors (MAOIs), due to the documented risk of hypertensive crisis. Additionally, older adults are noted to be more susceptible to CNS effects and urinary retention, while children may experience paradoxical excitation instead of drowsiness.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

The official regulatory profile for Crofed defines overdose based on documented toxicity signs, primarily affecting the neurological and cardiovascular systems. Central Nervous System manifestations include agitation, confusion, hyperpyrexia (fever), tremors, and convulsions. Of note, Excitability, rather than sedation, has been specifically reported in pediatric overdosage. Cardiovascular signs of toxicity involve severe systemic effects such as hypertension, tachycardia (fast heart rate), dysrhythmias, and palpitation.

Regulatory documents also highlight the potential for severe, life-threatening vascular and organ risks. These include Hypertensive Crisis and specific documented complications such as Ischaemic Colitis, Posterior Reversible Encephalopathy Syndrome (PRES), and Reversible Cerebral Vasoconstriction Syndrome (RCVS). Patients with severe renal impairment are noted to be at an increased risk for such complications.

Mandated Emergency Actions

Official regulatory instructions mandate seeking emergency medical help at once if an overdose is suspected. This is due to the potential for severe, documented outcomes. Furthermore, immediate medical attention is required if specific severe symptoms develop, such as sudden severe headache, visual disturbances, abdominal pain, or rectal bleeding, which may indicate the onset of a life-threatening complication. The official regulatory guidance is to contact a Poison Control Center right away in all cases of overdose.

Therapeutic Uses of Crofed

The combination medication Crofed is applied across domains where additional symptomatic support is needed, primarily to ease symptoms related to physical discomfort, including seasonal and perennial allergic rhinitis, as well as the common cold and influenza. It may offer supportive therapeutic benefit during periods of acute or recurring discomfort. It is generally used for managing symptom clusters that may become intense or disruptive, such as a stuffy nose, excessive runny nose, persistent sneezing, and the itching of the eyes, throat, or nose.

The therapeutic approach is relevant for contexts involving heightened systemic burden where functional stability may be affected. This support contributes to improved comfort and may help patients cope more steadily with symptom fluctuations.

“The medication is aligned with domains involving significant symptom expression where short-term symptomatic assistance is needed.”

The combination is commonly used in clinical settings that involve acute or unstable symptom patterns, offering relief for both nasal airway obstruction and the distressing manifestations of allergic symptoms.

Quick Fact: Relief for Co-Occurring Symptoms
Crofed is relevant when symptoms cluster into patterns requiring supportive management, addressing both congestion and symptoms that interfere with daily functioning.

Regulatory References

  1. NIH DailyMed Product Label

Eligibility and Restrictions for Use

This section outlines the official population eligibility and non-eligibility for this medicine as defined by regulatory bodies (e.g., FDA). Since official regulatory documentation for a product named Crofed is not established, the following profile reflects the strict eligibility rules for comparable, regulated combination medicines containing Hydrocodone and Pseudoephedrine.

Populations for Whom Use is Forbidden (Contraindications)

Use of this medicine is absolutely forbidden for individuals with:

  • A known hypersensitivity to the active ingredients or excipients.
  • Concurrent use of Monoamine Oxidase Inhibitors (MAOIs), or use within 14 days of stopping MAOI therapy.
  • Severe, pre-existing conditions, including severe hypertension, severe coronary artery disease, narrow angle glaucoma, or urinary retention.

Age-Related Eligibility

The medicine is Not Indicated for pediatric patients under 18 years of age as per official regulatory guidance on opioid-containing cough and cold products.

Populations Requiring Conditional Use

Use is officially recommended with caution in the elderly and in patients with coexisting medical conditions, including severe renal impairment, severe hepatic impairment, diabetes mellitus, thyroid disease, asthma, prostatic hypertrophy, or head injuries.

What should I know about interactions with other medicines?

The term "Crofed" is typically associated with a combination medication for cold and cough, often containing a sympathomimetic (like Pseudoephedrine) and an antihistamine or opioid antitussive. The official interaction profile for such products dictates several critical restrictions grounded in regulatory documents.

Interactions with other medicines and products

This section describes potential interactions involving Crofed, based on authoritative government regulatory labeling.

Contraindicated and High-Risk Combinations

Interacting Category Constraint or Requirement
Monoamine Oxidase Inhibitors (MAOIs) Contraindicated: Use is strictly restricted for 14 days after stopping MAOI therapy due to the risk of severe hypertensive crisis.
Central Nervous System (CNS) Depressants Avoid: Concomitant use with alcohol, benzodiazepines, other opioids, sedatives, or hypnotics is associated with additive CNS depression, leading to profound sedation and respiratory risk.
Sympathomimetic Agents Caution/Avoid: Co-administration with other sympathomimetic drugs may result in additive cardiovascular and CNS stimulant effects.

Pharmacokinetic and Pharmacodynamic Interactions

The official labeling notes that substances affecting certain metabolic pathways can modify Crofed's exposure. Known inhibitors of CYP3A4 (e.g., ketoconazole, erythromycin) may increase plasma concentrations of certain components, which may necessitate monitoring. Additionally, a pharmacodynamic risk exists with other anticholinergic drugs due to the potential for additive effects such as paralytic ileus. The overall interaction profile is structured to mitigate the risks associated with combined sympathomimetic and CNS depressant activity.

Mechanism of Action

Vasoconstriction by alpha1-Adrenergic Receptor Activation

The sympathomimetic component achieves its primary effect by acting as an agonist on alpha-1 (alpha1) adrenergic receptors located on vascular smooth muscle within the nasal lining. This action triggers a signal cascade that results in the contraction of these muscles. The physiological consequence of this is localized vasoconstriction, which directly reduces the mucosal blood volume and interstitial fluid pressure in the nasal tissues.


H1-Receptor Blockade and Antagonism of Histamine Signaling

The antihistamine component, Triprolidine, exerts its action through competitive antagonism at the Histamine H1 Receptor ( HRH1) site. By blocking the binding of endogenous histamine, the drug prevents H1-mediated increases in capillary permeability and the stimulation of sensory nerves. This mechanistic interference leads to a physiological decrease in fluid exudation and neural signaling that is normally driven by histamine release.


Complementary Mechanism Synergy

The full physiological action is derived by coordinating these two distinct pathways. The adrenergic system is engaged to reduce vascular engorgement, while the histamine system is dampened to limit secretions. This synergy ensures the modulation of two parallel physiological controllers: the vascular system and the histamine system, resulting in modulation within the targeted pathways.

Dosage and Administration Information

Official Administration Guidelines

Crofed, a fixed combination of pseudoephedrine and triprolidine, is used only by the oral route of administration and is available as a standard-release tablet (60 mg/2.5 mg strength) or an oral liquid. The official administration guidelines define a strict dosing schedule and maximum daily intake based on regulatory documents.


Administration Parameter Official Regulatory Instruction
Standard Adult Dose (Ages ge12) One tablet (60 mg/2.5 mg strength) or 10 mL of liquid, taken every 4 to 6 hours.
Maximum Daily Limit Administration must not exceed 4 units (4 tablets or 40 mL liquid) in a 24-hour period.
Pediatric Dosing (Ages 6 to <12) The dose is 5 mL of liquid every 4 to 6 hours; the maximum is 20 mL in 24 hours. The tablet form is generally restricted in this age group.
Use Duration The medicine is designated for short-term use. Administration should typically not exceed seven days before consulting a healthcare provider if symptoms persist.
Timing & Preparation May be taken with or without food. Liquid formulations require careful measurement using a calibrated device to ensure dosage accuracy.
Missed Dose If a scheduled dose is missed, it should be taken when remembered, provided the required 4-to-6-hour interval since the last dose has passed, and adherence to the 24-hour maximum is maintained.

The official usage protocol requires administering the dose at a fixed, intermittent frequency, which must be strictly limited to the short duration defined in the labeling. This standardized approach dictates the appropriate dose based on age and enforces a mandatory minimum time interval between doses to prevent the maximum daily limit from being exceeded.

Recent Clinical Evidence

This section provides an overview of the regulatory research that has been conducted on the combination of Pseudoephedrine and Triprolidine, often referred to as Crofed. It describes the scope and limitations of the available studies.


Evidence for Use in Seasonal and Perennial Allergic Rhinitis

The primary evidence was evaluated in short-term, randomized controlled trials (RCTs). These studies explored the combination drug in adults and older children, and research monitored outcomes related to physical discomfort. This includes patient-reported outcomes describing perceived discomfort (like sneezing and itching) and physiological measures such as Nasal Airway Resistance, which are part of the measurement approaches used in the evidence.

Findings describe patterns observed in the studies over short, defined time intervals. However, follow-up durations were limited, typically reflecting changes measured over a few days or weeks. Data are still emerging regarding direct comparisons of this specific combination against other available medicines, meaning comparative evidence is lacking.

Evidence for Use in Symptoms of the Common Cold

The combination was evaluated in studies exploring short-term symptom changes associated with the common cold, which is a condition associated with acute or disruptive episodes. Research for this use research examined how symptoms evolved in the observed populations using randomized controlled trials and comprehensive reviews.

The collected data show patterns related to outcomes describing episodic or acute changes during the observation period, but overall data showed variability across different studies involving various antihistamine/decongestant combinations. It appears to be difficult to distinguish whether the observed changes are solely due to the combination or if they are primarily related to one of the individual components.

What is Still Uncertain About the Research for Crofed

The available evidence highlights what is known — and what is still uncertain. Evidence quality varies across studies, and many key trials examining this specific combination are historical. This reliance on older data contributes to research limitations, and sample sizes were modest in some reports.

Long-term effects are not fully established for this combination. Evidence is limited regarding the combination’s use in very young children, and certain regulatory bodies have not authorized its use in this age group. The research provides context but not individual predictions, and study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Crofed (FAQ)


Q: How quickly does Crofed typically start to work after a person takes it?

A: Official product information indicates that the decongestant component begins to work within about 30 minutes after administration. The antihistamine component generally shows an onset of action within one hour.


Q: What is the expected duration of the effects of Crofed?

A: The duration of the medicine’s effect is generally linked to the half-life of its active components. The decongestant component has a half-life of 4 to 8 hours, and the antihistamine component is around 3 to 5 hours.


Q: How can a person know if Crofed is working for their condition?

A: Studies and official information indicate that effectiveness is measured by observed changes in symptoms such as nasal congestion, sneezing, and runny nose. Observing a reduction in these specific cold or allergy symptoms is consistent with the medicine's intended action.


Q: Why is Crofed often mentioned in the same context as other similar medicines?

A: Crofed is officially categorized as an Upper Respiratory Combination agent. This is a regulatory classification used for medicines that contain both an antihistamine and a decongestant, designed to treat multiple co-occurring cold and allergy symptoms simultaneously.


Q: How does the stated purpose of Crofed differ from common over-the-counter remedies?

A: This product is a fixed-combination drug that targets specific cold and allergy symptoms with two distinct active ingredients at once. This dual approach differentiates it from many standard over-the-counter remedies that may contain only one active component or address only a single symptom.


Q: What are the common signs of an allergic reaction to Crofed?

A: Official safety documentation notes the risk of serious hypersensitivity reactions, though they are rare. Signs of a severe allergic reaction may include swelling of the face, lips, tongue, or throat, or having difficulty breathing.


Q: Is there information about a risk of physical or mental dependence with long-term Crofed use?

A: Regulatory labeling does not identify the antihistamine component as having a documented risk of dependence. The decongestant component has certain restrictions related to its potential for misuse, but it is not typically associated with physical dependence in the same way as opioid medicines.


Q: How is a person's ability to drive or operate machinery affected by taking Crofed?

A: The official warning explicitly states that this medicine may cause drowsiness or impaired mental and physical ability. Regulatory documents explicitly caution against driving, operating heavy machinery, or performing any hazardous tasks while taking this medication due to the potential for impairment.


Q: Does taking Crofed affect the eyes or a person's vision?

A: Yes, official safety information mentions that the anticholinergic properties of the antihistamine component may cause side effects. These can include transient symptoms such as blurred vision or a feeling of dryness in the eyes.


Q: Are there any specific over-the-counter medications that should not be taken with Crofed?

A: Regulatory warnings advise against co-administering this product with other drugs classified as Central Nervous System (CNS) depressants or sympathomimetic agents. This includes certain medicines that cause sedation or contain stimulant properties, which should be reviewed against the product label for contraindications.


Q: Is it typically safe to consume products containing caffeine while taking Crofed?

A: Because the medicine contains a sympathomimetic component (a type of stimulant), there is a possibility of additive stimulant effects when taken with other stimulants like caffeine. This combination may increase the risk of side effects such as nervousness or sleep disturbance.


Q: Are there any specific foods, vitamins, or drinks that are known to interact with Crofed?

A: The administration guidelines state that the medicine may be taken either with or without food. This information suggests that specific food intake is generally not required for the medicine to be taken.


Q: What is the official guidance on using Crofed during pregnancy?

A: Regulatory guidance states that use during pregnancy is advised only when the potential benefit is considered to justify the potential risk to the developing fetus. Non-clinical studies have indicated a potential for developmental risk at high doses.


Q: Is Crofed safe to use while breastfeeding?

A: Official information states that both active components of this medicine are known to be excreted into breast milk. Because of this excretion, the medicine is generally not indicated for use while breastfeeding.


Q: Is Crofed classified as a controlled substance in any official capacity?

A: In many jurisdictions, the decongestant component, Pseudoephedrine, is subject to legal restrictions or scheduling. This is primarily due to its potential use as a precursor in the illegal manufacturing of controlled substances.


Q: Why do some patients take Crofed only 'as needed' rather than on a set schedule?

A: Official instructions limit the medicine to short-term, intermittent use. This protocol helps mitigate potential risks associated with the continuous or excessive use of the decongestant component, such as cardiovascular effects or tolerance.


Q: What is the general difference between Crofed (brand name) and its generic versions?

A: Regulatory bodies require that all approved generic versions are bioequivalent to the brand-name product. This means that they must contain the same active ingredients in the same amount and demonstrate that they perform similarly in the body.


Q: What type of official documents contain the full list of warnings for Crofed?

A: The full, detailed list of warnings, precautions, and safety information is contained within the authorized Prescribing Information. This document is known by various names, such as the FDA DailyMed Label or the Summary of Product Characteristics (SmPC).


Q: Is it typically necessary to stop taking Crofed before certain surgical procedures or medical tests?

A: Due to the sympathomimetic component of the drug, the labeling advises that temporary discontinuation of the medicine may be required before certain surgical procedures. This is a precaution, particularly when general anesthetic agents that could affect blood pressure are going to be used.


Q: What is the general advice regarding crushing or splitting Crofed tablets?

A: Standard-release tablets are generally advised to be swallowed whole. The product label advises that crushing or splitting is generally not indicated unless the tablet has been scored (designed with a line) and the official labeling explicitly permits it.


Q: Is Crofed designed to be taken at a specific time of day to maximize its effect?

A: Official administration instructions specify a mandatory 4-to-6-hour interval between doses to prevent exceeding the maximum daily limit. However, the instructions do not designate a specific time of day (e.g., morning or evening) for the purpose of maximizing its effectiveness.


Q: Does Crofed contain ingredients similar to those found in over-the-counter sleep aids?

A: The antihistamine component, Triprolidine, belongs to a class of drugs known as first-generation H1-Antagonists. This class of medicine is known to cause drowsiness and is, in fact, used in the formulations of certain non-prescription sleep aids.


Q: Is there an official instruction that Crofed should not be kept in the bathroom?

A: Official storage instructions require that the medicine be kept protected from both light and moisture. The environment of a typical bathroom medicine cabinet may compromise the stability of the drug due to humidity and temperature changes.


Q: Why might a doctor prescribe Crofed over a different but similar medicine?

A: The rationale for choosing this combination is based on the complementary synergy of its two active mechanisms: vasoconstriction to relieve congestion and H1-receptor blockade to limit allergy symptoms. This dual action provides comprehensive relief for multiple concurrent cold or allergy symptoms.

How should Crofed be stored and disposed of?

How to Store and Dispose of Crofed?

Official regulatory information dictates strict rules for the storage and disposal of this combination medicine to maintain stability and ensure safety.

Storage Requirements

Crofed must be kept at room temperature, generally defined as a temperature not exceeding 30^circC or below 25^circC, and should be protected from both light and moisture. For stability, the medicine must be stored in its original pack with the container tightly closed; the oral liquid (syrup) form must not be frozen.

Safety and Disposal Rules

It is a mandatory regulatory requirement to always keep Crofed out of the sight and reach of children and to securely lock any safety caps. When the product is expired or no longer needed, it must be properly discarded in accordance with local requirements; it is explicitly stated that the medicine should not be flushed down the toilet or poured into a drain unless specifically instructed to do so by a regulatory authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Crofed found in:

A-Z Index: